TP53 and cervical cancer: In some reports, HPV have been shown to modulate the expression of lncRNAs in cervical cancer, independent of the known targets of HR-HPV oncoproteins, p53/E6AP, the altered lncRNAs in cervical cancer include Fanconi anemia complementation group-2 (FANCI-2) (Liu et al., 2021), Family With Sequence Similarity 83 Member H antisense RNA 1 (FAM83H-AS1) (Barr et al., 2019) and Thymopoietin pseudogene 2 (TMPOP2) (He et al., 2019b).